231 related articles for article (PubMed ID: 29708829)
1. The impact of testosterone replacement therapy on glycemic control, vascular function, and components of the metabolic syndrome in obese hypogonadal men with type 2 diabetes.
Groti K; Žuran I; Antonič B; Foršnarič L; Pfeifer M
Aging Male; 2018 Sep; 21(3):158-169. PubMed ID: 29708829
[TBL] [Abstract][Full Text] [Related]
2. Adding liraglutide to lifestyle changes, metformin and testosterone therapy boosts erectile function in diabetic obese men with overt hypogonadism.
Giagulli VA; Carbone MD; Ramunni MI; Licchelli B; De Pergola G; Sabbà C; Guastamacchia E; Triggiani V
Andrology; 2015 Nov; 3(6):1094-103. PubMed ID: 26447645
[TBL] [Abstract][Full Text] [Related]
3. Testosterone treatment longer than 1 year shows more effects on functional hypogonadism and related metabolic, vascular, diabetic and obesity parameters (results of the 2-year clinical trial).
Groti Antonič K; Antonič B; Žuran I; Pfeifer M
Aging Male; 2020 Dec; 23(5):1442-1454. PubMed ID: 32844712
[TBL] [Abstract][Full Text] [Related]
4. Effects of testosterone replacement therapy on metabolic syndrome among Japanese hypogonadal men: A subanalysis of a prospective randomised controlled trial (EARTH study).
Shigehara K; Konaka H; Nohara T; Izumi K; Kitagawa Y; Kadono Y; Iwamoto T; Koh E; Mizokami A; Namiki M
Andrologia; 2018 Feb; 50(1):. PubMed ID: 28497534
[TBL] [Abstract][Full Text] [Related]
5. Effects of testosterone undecanoate replacement and withdrawal on cardio-metabolic, hormonal and body composition outcomes in severely obese hypogonadal men: a pilot study.
Francomano D; Bruzziches R; Barbaro G; Lenzi A; Aversa A
J Endocrinol Invest; 2014 Apr; 37(4):401-11. PubMed ID: 24639122
[TBL] [Abstract][Full Text] [Related]
6. Testosterone replacement therapy improves metabolic parameters in hypogonadal men with type 2 diabetes but not in men with coexisting depression: the BLAST study.
Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P;
J Sex Med; 2014 Mar; 11(3):840-56. PubMed ID: 24308723
[TBL] [Abstract][Full Text] [Related]
7. Testosterone therapy reduces insulin resistance in men with adult-onset testosterone deficiency and metabolic syndrome. Results from the Moscow Study, a randomized controlled trial with an open-label phase.
Tishova Y; Kalinchenko S; Mskhalaya G; Hackett G; Livingston M; König C; Strange R; Zitzmann M; Mann A; Maarouf A; Ramachandran S
Diabetes Obes Metab; 2024 Jun; 26(6):2147-2157. PubMed ID: 38433502
[TBL] [Abstract][Full Text] [Related]
8. Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 24-month, randomized, double-blind, placebo-controlled study.
Aversa A; Bruzziches R; Francomano D; Rosano G; Isidori AM; Lenzi A; Spera G
J Sex Med; 2010 Oct; 7(10):3495-503. PubMed ID: 20646185
[TBL] [Abstract][Full Text] [Related]
9. Effects of testosterone on Type 2 diabetes and components of the metabolic syndrome.
Jones TH
J Diabetes; 2010 Sep; 2(3):146-56. PubMed ID: 20923480
[TBL] [Abstract][Full Text] [Related]
10. Testosterone therapy has positive effects on anthropometric measures, metabolic syndrome components (obesity, lipid profile, Diabetes Mellitus control), blood indices, liver enzymes, and prostate health indicators in elderly hypogonadal men.
Canguven O; Talib RA; El Ansari W; Yassin DJ; Salman M; Al-Ansari A
Andrologia; 2017 Dec; 49(10):. PubMed ID: 28295504
[TBL] [Abstract][Full Text] [Related]
11. Effects of long-term testosterone replacement therapy, with a temporary intermission, on glycemic control of nine hypogonadal men with type 1 diabetes mellitus - a series of case reports.
Saad F; Yassin A; Almehmadi Y; Doros G; Gooren L
Aging Male; 2015; 18(3):164-8. PubMed ID: 26075537
[TBL] [Abstract][Full Text] [Related]
12. Metabolic Effects of Testosterone Therapy in Men with Type 2 Diabetes and Metabolic Syndrome.
Hackett G
Sex Med Rev; 2019 Jul; 7(3):476-490. PubMed ID: 30803918
[TBL] [Abstract][Full Text] [Related]
13. Hypogonadal obese men with and without diabetes mellitus type 2 lose weight and show improvement in cardiovascular risk factors when treated with testosterone: an observational study.
Haider A; Saad F; Doros G; Gooren L
Obes Res Clin Pract; 2014; 8(4):e339-49. PubMed ID: 25091355
[TBL] [Abstract][Full Text] [Related]
14. Treatment of hypogonadism with testosterone in patients with type 2 diabetes mellitus.
Gopal RA; Bothra N; Acharya SV; Ganesh HK; Bandgar TR; Menon PS; Shah NS
Endocr Pract; 2010; 16(4):570-6. PubMed ID: 20150021
[TBL] [Abstract][Full Text] [Related]
15. Metabolic effects of testosterone replacement therapy on hypogonadal men with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials.
Cai X; Tian Y; Wu T; Cao CX; Li H; Wang KJ
Asian J Androl; 2014; 16(1):146-52. PubMed ID: 24369149
[TBL] [Abstract][Full Text] [Related]
16. Effect of testosterone replacement therapy on sexual function and glycemic control among hypogonadal men with type 2 diabetes mellitus.
Shigehara K; Konaka H; Kato Y; Iijima M; Nakashima K; Kawaguchi S; Nohara T; Izumi K; Namiki M; Mizokami A
Int J Impot Res; 2019 Jan; 31(1):25-30. PubMed ID: 30135606
[TBL] [Abstract][Full Text] [Related]
17. Influence of testosterone substitution on glycemic control and endothelial markers in men with newly diagnosed functional hypogonadism and type 2 diabetes mellitus: a randomized controlled trial.
Khripun I; Vorobyev S; Belousov I; Kogan M; Zitzmann M
Aging Male; 2019 Dec; 22(4):241-249. PubMed ID: 30235049
[TBL] [Abstract][Full Text] [Related]
18. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
Blick G
Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
[TBL] [Abstract][Full Text] [Related]
19. Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study).
Jones TH; Arver S; Behre HM; Buvat J; Meuleman E; Moncada I; Morales AM; Volterrani M; Yellowlees A; Howell JD; Channer KS;
Diabetes Care; 2011 Apr; 34(4):828-37. PubMed ID: 21386088
[TBL] [Abstract][Full Text] [Related]
20. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes.
Kapoor D; Goodwin E; Channer KS; Jones TH
Eur J Endocrinol; 2006 Jun; 154(6):899-906. PubMed ID: 16728551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
